- Home
- BBIO vs RRC Comparison
BBIO vs RRC Comparison
Compare BBIO & RRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BBIO
- RRC
- Stock Information
- Founded
- BBIO 2015
- RRC 1976
- Country
- BBIO United States
- RRC United States
- Employees
- BBIO N/A
- RRC N/A
- Industry
- BBIO Biotechnology: Pharmaceutical Preparations
- RRC Oil & Gas Production
- Sector
- BBIO Health Care
- RRC Energy
- Exchange
- BBIO Nasdaq
- RRC Nasdaq
- Market Cap
- BBIO 9.4B
- RRC 8.4B
- IPO Year
- BBIO 2019
- RRC N/A
- Fundamental
- Price
- BBIO $53.33
- RRC $35.29
- Analyst Decision
- BBIO Strong Buy
- RRC Hold
- Analyst Count
- BBIO 16
- RRC 18
- Target Price
- BBIO $64.44
- RRC $43.06
- AVG Volume (30 Days)
- BBIO 2.1M
- RRC 2.8M
- Earning Date
- BBIO 11-11-2025
- RRC 10-21-2025
- Dividend Yield
- BBIO N/A
- RRC 1.01%
- EPS Growth
- BBIO N/A
- RRC 0.32
- EPS
- BBIO N/A
- RRC 1.98
- Revenue
- BBIO $235,812,000.00
- RRC $2,799,229,500.00
- Revenue This Year
- BBIO $115.97
- RRC $30.36
- Revenue Next Year
- BBIO $65.50
- RRC $14.88
- P/E Ratio
- BBIO N/A
- RRC $17.95
- Revenue Growth
- BBIO 7.62
- RRC 19.93
- 52 Week Low
- BBIO $21.72
- RRC $28.99
- 52 Week High
- BBIO $54.60
- RRC $43.50
- Technical
- Relative Strength Index (RSI)
- BBIO 60.01
- RRC 53.75
- Support Level
- BBIO $49.94
- RRC $34.69
- Resistance Level
- BBIO $54.29
- RRC $36.36
- Average True Range (ATR)
- BBIO 2.06
- RRC 0.87
- MACD
- BBIO -0.18
- RRC 0.22
- Stochastic Oscillator
- BBIO 73.81
- RRC 58.53
About BBIO BridgeBio Pharma Inc.
BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis) , is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.
About RRC Range Resources Corporation
Fort Worth-based Range Resources is an independent exploration and production company with that focuses entirely on its operations in the Marcellus Shale in Pennsylvania. At year-end 2024, Range Resources' proven reserves totaled 18.1 trillion cubic feet equivalent, with net production of 2.18 billion cubic feet equivalent per day. Natural gas accounted for 68% of production.